top of page


References and Links to Papers

1)  Quantification of Daily-Living Gait Quantity and Quality Using a Wrist-Worn Accelerometer in Huntington's Disease.

Keren K, Busse M, Fritz NE, Muratori LM, Gazit E, Hillel I, Scheinowitz M, Gurevich T, Inbar N, Omer N, Hausdorff JM, Quinn L.

Front Neurol. 2021 Oct 27;12:719442. doi: 10.3389/fneur.2021.719442. eCollection 2021.PMID: 34777196 

2) Body mass, cardiorespiratory fitness, and cardiometabolic risk over time: Findings from the Cooper Center Longitudinal Study.

Leonard D, Shuval K, Finley CE, Barlow CE, Haskell WL, Farrell SW, Pavlovic A, DiPietro L, Scheinowitz M, DeFina LF.Prev Med. 2021 Sep;150:106720. doi: 10.1016/j.ypmed.2021.106720. Epub 2021 Jul 10.PMID: 34252504

3) A Machine Learning Approach to the Interpretation of Cardiopulmonary Exercise Tests: Development and Validation.

Inbar O, Inbar O, Reuveny R, Segel MJ, Greenspan H, Scheinowitz M.

Pulm Med. 2021 May 31;2021:5516248. doi: 10.1155/2021/5516248. eCollection 2021.PMID: 34158976 Free PMC

4) Assessing rectal temperature with a novel non-invasive sensor.

Tsadok I, Scheinowitz M, Shpitzer SA, Ketko I, Epstein Y, Yanovich R.

J Therm Biol. 2021 Jan;95:102788. doi: 10.1016/j.jtherbio.2020.102788. Epub 2020 Nov 17.PMID: 33454029

5) Commentaries on Viewpoint: Time to reconsider how ventilation is regulated above the respiratory compensation point during incremental exercise.

Sheel AW, Scheinowitz M, Iannetta D, Murias JM, Keir DA, Balmain BN, Wilhite DP, Babb TG, Toffoli G, Silva BM, da Silva GSF, Gruet M, Romain AJ, Pageaux B, Sousa FAB, Rodrigues NA, de Araujo GG, Bossi AH, Hopker J, Brietzke C, Pires FO, Angius L

J Appl Physiol (1985). 2020 May 1;128(5):1450-1455. doi: 10.1152/japplphysiol.00259.2020.PMID: 32412390 Free article. No abstract available.

6) A new cardiac phantom for dynamic SPECT.

Krakovich A, Zaretsky U, Moalem I, Naimushin A, Rozen E, Scheinowitz M, Goldkorn R.J Nucl Cardiol.

2021 Oct;28(5):2299-2309. doi: 10.1007/s12350-020-02028-0. Epub 2020 Jan 29.PMID: 31997101

7) A Pulsed Electromagnetic Field Therapy Device for Non-Specific Low Back Pain: A Pilot Randomized Controlled Trial.

Lisi AJ, Scheinowitz M, Saporito R, Onorato A.

Pain Ther. 2019 Jun;8(1):133-140. doi: 10.1007/s40122-019-0119-z. Epub 2019 Mar 12.PMID: 30868475 Free PMC article.

8) Prediction of the Wingate anaerobic mechanical power outputs from a maximal incremental cardiopulmonary exercise stress test using machine-learning approach.

Leopold E, Navot-Mintzer D, Shargal E, Tsuk S, Tuller T, Scheinowitz

M.PLoS One. 2019 Mar 12;14(3):e0212199. doi: 10.1371/journal.pone.0212199. eCollection 2019.PMID: 30861009 Free PMC article.

9) Cardiac KATP channel modulation by 16Hz magnetic fields - A theoretical study.

Aharonovich Y, Scheinowitz M, Zlochiver S.

Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:161-164. doi: 10.1109/EMBC.2016.7590665.PMID: 28268304

10) Effect of cardiovascular and muscular endurance is not associated with stress fracture incidence in female military recruits: a 12-month follow up study.

Scheinowitz M, Yanovich R, Sharvit N, Arnon M, Moran DS.

J Basic Clin Physiol Pharmacol. 2017 May 1;28(3):219-224. doi: 10.1515/jbcpp-2015-0098.PMID: 28222029

11) Weak electromagnetic fields alter Ca(2+) handling and protect against hypoxia-mediated damage in primary newborn rat myotube cultures.

Adler D, Fixler D, Scheinowitz M, Shainberg A, Katz A.

Pflugers Arch. 2016 Aug;468(8):1459-65. doi: 10.1007/s00424-016-1837-2. Epub 2016 May 18.PMID: 27194243

12) Poly(methyl methacrylate) particles for local drug delivery using shock wave lithotripsy: In vitro proof of concept experiment.

Shaked E, Shani Y, Zilberman M, Scheinowitz M.

J Biomed Mater Res B Appl Biomater. 2015 Aug;103(6):1228-37. doi: 10.1002/jbm.b.33301. Epub 2014 Oct 28.PMID: 25350479

13) Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.

Shechter M, Shalmon G, Scheinowitz M, Koren-Morag N, Feinberg MS, Harats D, Sela BA, Sharabi Y, Chouraqui P.

Am J Cardiol. 2011 May 1;107(9):1255-61. doi: 10.1016/j.amjcard.2010.12.035. Epub 2011 Feb 23.PMID: 21349479 Clinical Trial.

14) Platelet reactivity in diabetic patients subjected to acute exercise stress test.

Scheinowitz M, Pakala R, Ben-Dor I, Lemesle G, Torguson R, Pichard AD, Lindsay J, Waksman R.

Cardiovasc Revasc Med. 2011 Jan-Feb;12(1):20-4. doi: 10.1016/j.carrev.2010.01.005. Epub 2010 Oct 20.PMID: 21241967

15) Long-term trajectory of leisure time physical activity and survival after first myocardial infarction: a population-based cohort study.

Gerber Y, Myers V, Goldbourt U, Benyamini Y, Scheinowitz M, Drory Y.

Eur J Epidemiol. 2011 Feb;26(2):109-16. doi: 10.1007/s10654-010-9523-8. Epub 2010 Nov 30.PMID: 21116840

16) Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents.

Ben-Dor I, Torguson R, Scheinowitz M, Li Y, Delhaye C, Wakabayashi K, Maluenda G, Syed AI, Collins SD, Gonzalez MA, Gaglia MA Jr, Xue Z, Kaneshige K, Satler LF, Suddath WO, Kent KM, Pichard AD, Waksman R.

Am Heart J. 2010 May;159(5):871-5. doi: 10.1016/j.ahj.2010.01.016.PMID: 20435198

17) Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

Syed AI, Kakkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):91-7. doi: 10.1016/j.carrev.2009.07.006.PMID: 20347798

18) Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

Li Y, Torguson R, Syed AI, Ben-Dor I, Collins SD, Maluenda G, Scheinowitz M, Kaneshige K, Xue Z, Lemesle G, Satler LF, Suddath WO, Kent KM, Lindsay J, Pichard AD, Waksman R.

Am J Cardiol. 2009 Dec 15;104(12):1654-9. doi: 10.1016/j.amjcard.2009.07.044.PMID: 19962470

19) Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

Pinto Slottow TL, Bonello L, Gavini R, Beauzile P, Sushinsky SJ, Scheinowitz M, Kaneshige K, Xue Z, Torguson R, Tantry U, Pichard AD, Satler LF, Suddath WO, Kent K, Gurbel P, Waksman R.

Am J Cardiol. 2009 Aug 15;104(4):525-30. doi: 10.1016/j.amjcard.2009.04.015. Epub 2009 Jun 24.PMID: 19660606

20) Electromagnetic field at 15.95-16 Hz is cardio protective following acute myocardial infarction.

Barzelai S, Dayan A, Feinberg MS, Holbova R, Laniado S, Scheinowitz M.

Ann Biomed Eng. 2009 Oct;37(10):2093-104. doi: 10.1007/s10439-009-9758-2. Epub 2009 Jul 9.PMID: 19588249

21) Effects of exogenous peripheral-blood-derived endothelial progenitor cells or unfractionated bone-marrow-derived cells on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated iliac arteries of inbred rabbits.

Waksman R, Baffour R, Pakala R, Scheinowitz M, Hellinga D, Seabron R, Chan R, Kolodgie F, Virmani R.

Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):110-6. doi: 10.1016/j.carrev.2009.02.001.PMID: 19327673

22) Paclitaxel-eluting balloon: from bench to bed.

De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M, Waksman R.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):643-52. doi: 10.1002/ccd.21895.PMID: 19309715 Review.

23) Exercise training alters the molecular response to myocardial infarction.

Freimann S, Kessler-Icekson G, Shahar I, Radom-Aizik S, Yitzhaky A, Eldar M, Scheinowitz M.

Med Sci Sports Exerc. 2009 Apr;41(4):757-65. doi: 10.1249/MSS.0b013e31819125b6.PMID: 19276859

24) Crossing chronic total occlusions with a new 0.014'' CiTop guidewire: proof of concept.

Scheinowitz M, Amrami I, Oppenhaim U, Engelberg S, Schwartz O, Belenky A, Siev-Ner I.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):278-85. doi: 10.1002/ccd.21978.PMID: 19198011

25) Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.

Bonello L, De Labriolle A, Scheinowitz M, Lemesle G, Roy P, Steinberg DH, Pinto Slottow TL, Pakala R, Pichard AD, Barragan P, Camoin-Jau L, Dignat-George F, Paganelli F, Waksman R.

Heart. 2009 Aug;95(15):1214-9. doi: 10.1136/hrt.2008.152660. Epub 2009 Feb 5.PMID: 19196732 Review.

26) IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.

Scheinowitz M, Feinberg MS, Laron Z.

Growth Horm IGF Res. 2009 Jun;19(3):280-2. doi: 10.1016/j.ghir.2008.11.004. Epub 2008 Dec 30.PMID: 19117781

27) [Pre-participation screening of individuals engaging in noncompetitive physical activity].

Scheinowitz M, Dankner R, Goldbourt U, Marom-Klibansky R.

Harefuah. 2008 Jul;147(7):611-7, 662, 661.PMID: 18814521 Review. Hebrew.

28) Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries.

Waksman R, Pakala R, Roy P, Baffour R, Hellinga D, Seabron R, Chan R, Scheinowitz M, Kolodgie F, Virmani R.

J Interv Cardiol. 2008 Apr;21(2):122-8. doi: 10.1111/j.1540-8183.2008.00347.x. Epub 2008 Feb 28.PMID: 18312301

29) How do normals move during prolonged wheelchair-sitting?

Linder-Ganz E, Scheinowitz M, Yizhar Z, Margulies SS, Gefen A.

Technol Health Care. 2007;15(3):195-202.PMID: 17473399

30) Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.

Shechter M, Ginsberg S, Scheinowitz M, Feinberg MS, Laron Z.

Growth Horm IGF Res. 2007 Apr;17(2):165-70. doi: 10.1016/j.ghir.2007.01.009. Epub 2007 Feb 22.PMID: 17320443

31) Evaluation of autonomic function underlying slow postexercise heart rate recovery.

Davrath LR, Akselrod S, Pinhas I, Toledo E, Beck A, Elian D, Scheinowitz M.

Med Sci Sports Exerc. 2006 Dec;38(12):2095-101. doi: 10.1249/01.mss.0000235360.24308.c7.PMID: 17146315

32) Low-intensity ultrasound induces angiogenesis in rat hind-limb ischemia.

Barzelai S, Sharabani-Yosef O, Holbova R, Castel D, Walden R, Engelberg S, Scheinowitz M.

Ultrasound Med Biol. 2006 Jan;32(1):139-45. doi: 10.1016/j.ultrasmedbio.2005.08.010.PMID: 16364805

33) Pressure-time cell death threshold for albino rat skeletal muscles as related to pressure sore biomechanics.

Linder-Ganz E, Engelberg S, Scheinowitz M, Gefen A.

J Biomech. 2006;39(14):2725-32. doi: 10.1016/j.jbiomech.2005.08.010. Epub 2005 Sep 30.PMID: 16199045

34) Doppler echocardiography flow-velocity image analysis for patients with atrial fibrillation.

Greenspan H, Shechner O, Scheinowitz M, Feinberg MS.

Ultrasound Med Biol. 2005 Aug;31(8):1031-40. doi: 10.1016/j.ultrasmedbio.2005.04.016.PMID: 16085094

35) Swimming exercise training prior to acute myocardial infarction attenuates left ventricular remodeling and improves left ventricular function in rats.

Dayan A, Feinberg MS, Holbova R, Deshet N, Scheinowitz M.

Ann Clin Lab Sci. 2005 Winter;35(1):73-8.PMID: 15830712

36) A new mechanical device for declotting of hemodialysis access grafts: first clinical experience.

Yoffe B, Behar DJ, Scheinowitz M, Rabin AM.

J Endovasc Ther. 2005 Apr;12(2):215-23. doi: 10.1583/04-1270R.1.PMID: 15823069 Clinical Trial.

37) Prior exercise training improves the outcome of acute myocardial infarction in the rat. Heart structure, function, and gene expression.

Freimann S, Scheinowitz M, Yekutieli D, Feinberg MS, Eldar M, Kessler-Icekson G.

J Am Coll Cardiol. 2005 Mar 15;45(6):931-8. doi: 10.1016/j.jacc.2004.11.052.PMID: 15766831 Free article.

38) Safety of cardiac rehabilitation in a medically supervised, community-based program.

Scheinowitz M, Harpaz D.

Cardiology. 2005;103(3):113-7. doi: 10.1159/000083433. Epub 2005 Jan 19.PMID: 15665529

39) Therapeutic myocardial angiogenesis: past, present and future.

Scheinowitz M.

Mol Cell Biochem. 2004 Sep;264(1-2):75-83. doi: 10.1023/b:mcbi.0000044376.78158.51.PMID: 15544037 Review.

40) Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome).

Ben-Dov I, Gaides M, Scheinowitz M, Wagner R, Laron Z.

Clin Endocrinol (Oxf). 2003 Dec;59(6):763-7. doi: 10.1046/j.1365-2265.2003.01920.x.PMID: 14974919

41) Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.

Feinberg MS, Scheinowitz M, Laron Z.

Am Heart J. 2003 Mar;145(3):549-53. doi: 10.1067/mhj.2003.175.PMID: 12660681

42) Dalteparin sodium (fragmin) administration following acute infarction does not affect myocardial perfusion and function in swine.

Scheinowitz M, Heled Y, Chouraqui P, Vered Z, Hayardeni Y, Kotlyar A, Castel D, Livschitz S, Barak V, Savion N, Eldar M.

Cardiovasc Drugs Ther. 2002 Jul;16(4):303-9. doi: 10.1023/a:1021777825386.PMID: 12652099

43) Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression.

Scheinowitz M, Kessler-Icekson G, Freimann S, Zimmermann R, Schaper W, Golomb E, Savion N, Eldar M.

Growth Horm IGF Res. 2003 Feb;13(1):19-25. doi: 10.1016/s1096-6374(02)00137-5.PMID: 12550078

44) Preliminary experience with the Xtrak debulking device in the treatment of peripheral occlusions.

Yoffe B, Yavnel L, Altshuler A, Scheinowitz M, Lebovici O.

J Endovasc Ther. 2002 Apr;9(2):234-40. doi: 10.1177/152660280200900218.PMID: 12010108

45) Effect of basic fibroblast growth factor on left ventricular geometry in rats subjected to coronary occlusion and reperfusion.

Scheinowitz M, Kotlyar AA, Zimand S, Leibovitz I, Varda-Bloom N, Ohad D, Goldberg I, Engelberg S, Savion N, Eldar M.

Isr Med Assoc J. 2002 Feb;4(2):109-13.PMID: 11875982

46) Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine.

Kotlyar AA, Vered Z, Goldberg I, Chouraqui P, Nas D, Fridman E, Chen-Levy Z, Fytlovich S, Sangiorgi G, Spagnoli LG, Orlandi A, Savion N, Eldar M, Scheinowitz M.

Heart. 2001 Dec;86(6):693-700. doi: 10.1136/heart.86.6.693.PMID: 11711471 Free PMC article.

47) Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome).

Feinberg MS, Scheinowitz M, Laron Z.

Am J Cardiol. 2000 Jan 15;85(2):209-13. doi: 10.1016/s0002-9149(99)00642-6.PMID: 10955379

48) Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats.

Scheinowitz M, Kotlyar A, Zimand S, Ohad D, Leibovitz I, Bloom N, Goldberg I, Nass D, Engelberg S, Savion N, Eldar M.

Exp Physiol. 1998 Sep;83(5):585-93. doi: 10.1113/expphysiol.1998.sp004140.PMID: 9793779

49) Continuous administration of insulin-like growth factor-I and basic fibroblast growth factor does not affect left ventricular geometry after acute myocardial infarction in rats.

Scheinowitz M, Abramov D, Kotlyar A, Savion N, Eldar M.

Int J Cardiol. 1998 Feb 28;63(3):217-21. doi: 10.1016/s0167-5273(97)00322-7.PMID: 9578347

50) Serum basic fibroblast growth factor levels in patients with ischemic heart disease.

Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M, Scheinowitz M.

Int J Cardiol. 1997 Apr 18;59(2):133-8. doi: 10.1016/s0167-5273(97)02921-5.PMID: 9158164

51) The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini review.

Scheinowitz M, Abramov D, Eldar M.

Int J Cardiol. 1997 Mar;59(1):1-5. doi: 10.1016/s0167-5273(96)02902-6.PMID: 9080019 Review.

52) Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF.

Circulation. 1996 Sep 1;94(5):1074-82. doi: 10.1161/01.cir.94.5.1074.PMID: 8790049

53) Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V.

Heart. 1996 Jul;76(1):24-8. doi: 10.1136/hrt.76.1.24.PMID: 8774323 Free PMC article.

54) The effects of short-term exercise on the cognitive orientation for health and adjustment in myocardial infarction patients.

Greif H, Kreitler S, Kaplinsky E, Behar S, Scheinowitz M.

Behav Med. 1995 Summer;21(2):75-85. doi: 10.1080/08964289.1995.9933746.PMID: 8845579

55) Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart.

Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, et al.

Circulation. 1995 Jan 1;91(1):145-53. doi: 10.1161/01.cir.91.1.145.PMID: 7805195

56) Neointimal proliferation in canine coronary arteries. A model of restenosis permitting local and continuous drug delivery.

Scheinowitz M, Shou M, Banai S, Gertz SD, Lazarous DF, Unger EF.

Lab Invest. 1994 Dec;71(6):813-9.PMID: 7632203

57) Normal cardiopulmonary responses during incremental exercise in 20- to 70-yr-old men.

Inbar O, Oren A, Scheinowitz M, Rotstein A, Dlin R, Casaburi R.

Med Sci Sports Exerc. 1994 May;26(5):538-46.PMID: 8007799

58) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF.

Circulation. 1994 May;89(5):2183-9. doi: 10.1161/01.cir.89.5.2183.PMID: 7514110

59) Basic fibroblast growth factor enhances myocardial collateral flow in a canine model.

Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE.

Am J Physiol. 1994 Apr;266(4 Pt 2):H1588-95. doi: 10.1152/ajpheart.1994.266.4.H1588.PMID: 8184938

60) Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium.

Battler A, Scheinowitz M, Bor A, Hasdai D, Vered Z, Di Segni E, Varda-Bloom N, Nass D, Engelberg S, Eldar M, et al.

J Am Coll Cardiol. 1993 Dec;22(7):2001-6. doi: 10.1016/0735-1097(93)90790-8.PMID: 7504006

61) Evaluation of a new mechanical atherectomy system (TRAC) in normal canine coronary arteries. Transluminal Rotary Atherectomy System.

Scheinowitz M, Eldar M, Rath S, Axelrod S, Battler A.

Coron Artery Dis. 1993 Sep;4(9):829-34. doi: 10.1097/00019501-199309000-00010.PMID: 8287217

62) The Bard Rotary Atherectomy System (BRAS): initial experience in patients with peripheral vascular disease.

Agmon M, Scheinowitz M, Beitner S, Bayer I, Rath S, Eldar M, Battler A.

J Interv Cardiol. 1993 Mar;6(1):51-9. doi: 10.1111/j.1540-8183.1993.tb00441.x.PMID: 10150986

63) Effect of isoproterenol on regional myocardial segment work, O2 consumption, and oxygen balance.

Kedem J, Sonn J, Scheinowitz M, Weiss HR.

Res Exp Med (Berl). 1992;192(5):323-34. doi: 10.1007/BF02576289.PMID: 1439197

64) Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits.

Eldar M, Yerushalmi Y, Kessler E, Scheinowitz M, Goldbourt U, Ben Hur E, Rosenthal I, Battler A.

Atherosclerosis. 1990 Oct;84(2-3):135-9. doi: 10.1016/0021-9150(90)90083-u.PMID: 2282094

65) Relationship between local oxygen consumption and local and external cardiac work: effect of tachycardia.

Kedem J, Sonn J, Scheinowitz M, Weiss HR.

Cardiovasc Res. 1989 Dec;23(12):1043-52. doi: 10.1093/cvr/23.12.1043.PMID: 2620323

66) Specific effects of nitroprusside on myocardial O2 balance following coronary ligation in the dog heart.

Acad B, Sonn J, Furman E, Scheinowitz M, Kedem J.

J Cardiovasc Pharmacol. 1987 Jan;9(1):79-86.PMID: 2434799


bottom of page